CA
NZ
UK
AU
IND
US
The acquisition brings Forte’s lead asset, the anti-CD122 antibody FB102, into argenx’s development stream, immediately expanding its therapeutic reach. Market participants reacted sharply as Forte’s stock surged 39%, underscoring investor optimism about the combined pipeline. The transaction, expected to close in the third quarter, …
The $1.50 per share price was set modestly above the closing price of the preceding trading session, reflecting a measured premium despite recent volatility in the stock. The proceeds are intended to support the company’s strategic initiatives.
Citigroup Global Markets Holdings Inc. has issued Medium-Term Senior Notes due October 29, 2029, structured as callable contingent coupon equity-linked securities tied to the performance of the Nasdaq-100, Russell 2000, and S&P 500 indexes. The securities offer potential periodic coupon payments at approximately 12.50% …
Citigroup Global Markets Holdings Inc. has priced a new offering of medium-term senior notes linked to the performance of Take-Two Interactive Software, Inc. stock. The securities, priced on July 24, 2026, feature contingent coupon payments at approximately 14.35% annualized if performance targets are met, …
Morgan Stanley Finance LLC announced the issuance of Callable Contingent Income Securities due February 1, 2029, according to a preliminary pricing supplement filed on July 28, 2026. The securities offer a contingent coupon of 10.00% annually but are fully exposed to principal risk, with …
Morgan Stanley Finance LLC has issued Contingent Income Memory Auto-Callable Securities due August 16, 2032, fully guaranteed by Morgan Stanley and tied to the performance of the S&P 500 Futures 40% Intraday 4% Decrement VT Index. The securities, priced at $1,000 per unit on …
Morgan Stanley Finance LLC has issued Contingent Income Memory Auto-Callable Securities due August 7, 2029, fully guaranteed by Morgan Stanley and linked to the performance of Space Exploration Technologies Corp. Class A common stock. The structured investment, filed on July 28, 2026, offers investors …
FOXO Technologies Inc. trading under the ticker FOXO, is moving forward with a strategic purchase through its wholly‑owned entity, Vector BioSource Inc. The transaction involves the acquisition of four U.S. The agreement outlines an upfront cash payment of $3,500,000 and provides for an additional …
Gossamer Bio (NASDAQ: GOSS) has secured a $5 million cash settlement from Chiesi, ending their 2024 collaboration and granting the company exclusive worldwide development and commercialization rights to seralutinib. The agreement terminates the prior license that divided U.S. profits with Chiesi, bringing all future …
Philips showed stronger than expected earnings performance for the second quarter of 2026, highlighting its capacity to meet market demands. Despite the company’s success in exceeding earnings predictions, investor reaction was tepid, resulting in a decline in share prices. This paradoxical situation points to …
Please wait processing your request...